IFNA1 and systemic lupus erythematosus: Here we found that targeting the CRISPRa system to the rs2431697-containing region can effectively decrease the IFN score by upregulating miR-146a expression in SLE patients’ PBMCs, suggesting that therapeutic manipulation of the enhancer region harboring rs2431697 could be applied to alleviate SLE development.